Year archive

Clover Biopharmaceuticals, Ltd. — 2026 filings

All 15 regulatory filings released by Clover Biopharmaceuticals, Ltd. (2197) in 2026, sourced directly from the official regulator.

15 Filings

2026 Period

2026 filings (15)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2026 Regulatory Filings	2026-05-06	English
Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2026-04-23	English
2025 Annual Report Annual Report FY 2025	2026-04-23	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2026 Share Issue/Capital Change	2026-04-09	English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO INSIDE INFORMATION Regulatory Filings	2026-04-02	English
Voluntary Announcement Clover Completes Enrollment in Australian Phase 2 Clinical Trial for RSV + hMPV + PIV3 Respiratory Combination Vaccine Candidates Regulatory Filings	2026-03-30	English
GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUs PURSUANT TO THE RSU SCHEME Director's Dealing	2026-03-27	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION Earnings Release FY 2025	2026-03-25	English
VOLUNTARY ANNOUNCEMENT CLOVER ANNOUNCES ADDITIONAL POSITIVE U.S. PHASE I CLINICAL DATA FOR RSV RE-VACCINATION IN OLDER ADULTS Regulatory Filings	2026-03-25	English
INSIDE INFORMATION Legal Proceedings Report	2026-03-22	English
DATE OF BOARD MEETING Report Publication Announcement	2026-03-13	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2026 Share Issue/Capital Change	2026-03-05	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2026 Share Issue/Capital Change	2026-02-04	English
VOLUNTARY ANNOUNCEMENT CLOVER INITIATES PHASE 2 CLINICAL TRIAL FOR RSV - HMPV - PIV3 RESPIRATORY COMBINATION VACCINE CANDIDATES Regulatory Filings	2026-01-12	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2025 Regulatory Filings	2026-01-07	English